Aquestive Therapeutics (AQST)

Aquestive Therapeutics (AQST) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• AQST last traded at $3.79, 0.53% on the day.
• Aquestive Therapeutics: market cap $473.18M, P/E -5.8, revenue $54.09M over the last four quarters.
• Over the past year AQST returned -44.43%; year to date -41.33%.

Updated 2026-11-04 00:09 UTC